Allergan plc (NYSE:AGN)

During the Trading Day
326.98 +18.77 / +6.09%
As of 4:04pm ET
Day’s Change
During After-Hours   Switch to standard view »
325.44 -1.54 / -0.47%
Volume: 13.4K
Benzinga's M&A Chatter for Monday July 27, 2015
7:58pm / Benzinga
Global Stocks, US Equity Futures Slide Following China Crash
8:48am / Investing Channel
Market Wrap: Chinese Stock Pressure Hits U.S. Markets; Durable Orders Outpace in June...
6:18pm / Investing Channel
Stock Futures Fall as Chinese Stocks Plummet
8:41am /
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period f...
5:55pm / Benzinga
Trade-Ideas: Allergan (AGN) Is Today's Pre-Market Leader Stock
8:16am /
Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
5:52pm /
US Stock Futures Signal Lower Start On Wall Street
8:08am / Benzinga
Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash
4:33pm /
Teva buys Allergan's generic drugs business for $40.5 billion
8:05am /
Allergan CEO: Teva Made A 'Compelling Offer' We Couldn't Refuse
4:23pm / Benzinga
July 27 Premarket Briefing: 10 Things You Should Know
6:56am /
Allergan signals appetite for new mega deal after $41bn disposal
4:17pm /
European Stocks Sharply Lower as Asian Stocks Drag
6:44am /
Stocks Down in the Dumps as Chinese Market Slumps
4:09pm /
Allergan sells generic drugs unit to Teva for $40bn
6:18am /
Is the U.S. Bull Market Starting to Lose Its Luster?
3:07pm /
Chinese Stocks Post Biggest One-Day Loss in Eight Years
5:33am /
3 Health Care Stocks to Trade for Gains
1:59pm /
Stocks: 5 things to know before the open
5:25am /
Pharma M&A: portfolio theory
1:47pm /
Futures Move Lower With Fed and GDP on Tap
Jul 26 /
Tread Carefully in the Market
1:02pm /
Futures Start Mixed with Fed and GDP on Tap
Jul 26 /
Weak sales outlook hits machinery makers
1:02pm /
Teva (TEVA) in Advanced Talks to Buy Allerganbs (AGN) Generic Drug Business: Source
Jul 26 / Investing Channel
Cramer's Charitable Trust: We Love This Possible Allergan Deal
12:33pm /
Cramer: Biogen's Horseman May Have Fallen Off, But These 3 Are Better
Jul 24 /
Teva Pharmaceutical to Buy Allergan's Generics Unit in $40.5 Billion Deal - Stocks in...
12:25pm /
Shire's (SHPG) Q2 Earnings Lag Estimates, 2015 View Raised - Analyst Blog
Jul 24 /
Stocks Extend Losing Streak as Oil Closes Below $48
12:07pm /
Drugmaker Mallinckrodt Looks Very Healthy
Jul 23 /
Stocks Hitting 52-Week Highs
11:13am / Benzinga
Zacks Industry Outlook Highlights: AbbVie, Allergan, Pfizer, Juno and Johnson & Johns...
Jul 22 /
Why Teva Pharmaceutical Industries Ltd. Stock Jumped Today
11:06am /
Pharma Stock Outlook - July 2015 - Zacks Analyst Interviews
Jul 21 /
Notable Mergers and Acquisitions 7/27: (TEVA)/(AGN) (WAB) (BECN) (SNY) (XUE)
11:01am / Investing Channel
Pharma Stock Outlook - July 2015 - Industry Outlook
Jul 21 /
Mylan share price plunges after Teva abandons bid
10:17am /
AstraZeneca Strikes Deal to Market Benralizumab in Japan - Analyst Blog
Jul 17 /
Allergan (AGN) Stock Rises After $40.5 Billion Generic Drug Business Sale
10:13am /
Allergan Faces Patent Challenge for Eye Treatment Restasis - Analyst Blog
Jul 16 /
Benzinga's Top #PreMarket Gainers
9:40am / Benzinga
US health insurers rush to consolidate after Obamacare ruling
Jul 08 /
Stocks Remain in Red After Chinese Market Slump
9:39am /
Teva prepares to raise its bid for Mylan
Jul 06 /
China Tanks as Q2 Marches On - Ahead of Wall Street
9:25am /

To view my watchlist

Not a member yet?

Sign up now for a free account